Industry Case Studies in Plymouth, Minnesota

The application of the United States federal and Minnesota state R&D tax credits is best understood through the lens of the specific industries that dominate the local economy. Plymouth, Minnesota, situated ten miles west of downtown Minneapolis, has evolved from a mid-19th-century agrarian settlement centered around the gristmills of Parkers Lake into a premier hub for advanced technology and manufacturing. This economic transformation was deliberately engineered. In the 1950s, entrepreneur Curtis Carlson acquired large tracts of land to establish the Minneapolis Industrial Park, while Mayor Al Hilde simultaneously drove the aggressive expansion of municipal sewer and transportation infrastructure. These foundational developments created an environment perfectly suited for the advanced manufacturing, medical technology, food science, and software sectors that define Plymouth today. The following five case studies illustrate the historical development of these industries in Plymouth and their eligibility for R&D tax credits under the federal Internal Revenue Code (IRC) Section 41 and Minnesota Statute Section 290.068.

Case Study: Medical Device Manufacturing and Image-Guided Therapy

The proliferation of the medical device industry in Plymouth is inextricably linked to the broader regional phenomenon known as “Medical Alley.” In 1957, University of Minnesota student Earl Bakken invented the first battery-powered, wearable cardiac pacemaker, laying the foundation for Medtronic and launching a regional technological revolution. Recognizing the unprecedented concentration of clinical and engineering expertise, Bakken, along with 3M executive Lee Berlin and Governor Rudy Perpich, formally established the Medical Alley association in 1984 to brand the region as the global epicenter of health technology. Plymouth, with its expansive industrial parks and highly educated workforce, became a primary destination for these firms. Today, the city hosts over 130 medical technology companies, including major divisions of Abbott Laboratories and Philips.

Abbott Laboratories operates a massive Structural Heart division in Plymouth, focusing on transcatheter valve repair technologies and left atrial appendage (LAA) occluders. Similarly, Philips announced a $31 million expansion of its Image-Guided Therapy facility in Plymouth in 2025, supported by the Minnesota Department of Employment and Economic Development (DEED), to advance AI-enabled medical scanning.

When a Plymouth-based medical device manufacturer develops a next-generation transcatheter aortic valve, the associated expenditures are highly eligible for both federal and state R&D tax credits. The research satisfies the federal four-part test as follows:

• Technological in Nature: The development relies on the fundamental principles of metallurgy (specifically the behavior of Nitinol alloys), fluid dynamics, and biological sciences to ensure long-term biocompatibility.
• Permitted Purpose: The objective is to improve the device’s deployment speed, seating reliability, and hemodynamic performance compared to existing market iterations.
• Elimination of Uncertainty: At the project’s inception, engineers face profound technical uncertainty regarding the optimal stent geometry required to prevent paravalvular leaks without causing tissue necrosis.
• Process of Experimentation: The engineering teams in Plymouth utilize Computer-Aided Design (CAD), finite element analysis (FEA), and physical bench testing (such as accelerated wear testing and radial force testing) to iterate through multiple prototype variations.

Because these design, engineering, and testing activities are physically conducted within the company’s Plymouth laboratories, the W-2 wages of the R&D engineers, the cost of raw materials consumed during prototyping, and 65 percent of the payments made to local clinical research organizations qualify for both the federal and the Minnesota state R&D tax credits.

Case Study: Advanced HVAC and Commercial Climate Technology

Plymouth’s industrial landscape is not limited to life sciences; it is also a center for heavy industrial manufacturing and commercial climate technology. The city’s strategic location near the intersection of Highway 55 and Interstate 494 provides critical logistical advantages for the transport of large-scale industrial equipment. As artificial intelligence (AI) workloads and cloud computing expand globally, the demand for hyperscale data centers has surged. These facilities generate immense thermal loads, necessitating highly specialized and innovative cooling solutions.

Capitalizing on this market demand, Daikin Applied, a global leader in commercial HVAC solutions, selected its Plymouth headquarters for the construction of a $163 million, 71,000-square-foot state-of-the-art R&D test laboratory. The facility is explicitly engineered to replicate the extreme operating environments of modern hyperscale data centers, allowing for the advanced testing of chillers, heat pumps, and airside technologies.

When Daikin Applied engineers develop a new magnetic-bearing compressor chiller utilizing ultra-low global warming potential (GWP) refrigerants, the activity qualifies robustly under R&D tax statutes. The work is technological in nature, relying on thermodynamics and mechanical engineering. The permitted purpose is to maximize energy efficiency, increase cooling capacity to environments operating at up to 131°F, and improve systemic resiliency. The engineers face significant uncertainty regarding how the new low-GWP refrigerants will interact with magnetic bearing systems under the high-ambient thermal loads generated by AI servers. To resolve this, the Plymouth test cells are utilized in a rigorous process of experimentation, simulating varying global climate conditions and electrical loads to evaluate compressor speeds and heat exchange geometries.

While the capital expenditure for constructing the $163 million building itself does not qualify for the R&D credit, as IRC Section 41 strictly excludes depreciable property and real estate acquisitions, the operational research expenditures do. The salaries of the mechanical engineers running the test cells, the software developers programming the variable frequency drives, and the prototype materials consumed during thermal stress testing are fully eligible for both state and federal tax offsets.

Case Study: Food Science and Biotechnology

Minnesota’s broader economic foundation was built upon agriculture and commodity processing, championed by historic institutions like General Mills and the Pillsbury Company. As consumer demands evolved toward sustainability, alternative proteins, and advanced nutrition, the state’s agricultural sector transitioned from traditional processing into high-tech food science. Plymouth serves as a central node in this evolution, hosting Cargill’s North American Food Innovation Center and Bioindustrial Center. This 106,000-square-foot facility houses over 200 food chemists, biotechnologists, and process engineers dedicated to ingredient innovation.

Cargill’s researchers in Plymouth frequently engage in complex biochemistry to develop functional ingredients, such as plant-based protein isolates or zero-waste fermentation processes to produce specialized sweeteners. This research is fundamentally technological in nature, relying on molecular biology, enzymology, and rheology. The permitted purpose is to enhance the sensory profile, nutritional yield, and shelf-life of food products while optimizing production costs. The exact formulation parameters, such as pH levels, temperature gradients, and enzyme concentrations required to scale a fermentation process without denaturing the target protein, present significant technical uncertainties. To eliminate this uncertainty, scientists utilize chromatography to analyze molecular structures, conduct controlled fermentation trials in pilot bioreactors, and iteratively adjust formulations based on empirical data.

A crucial statutory distinction must be observed in this sector. The IRS and the Minnesota Department of Revenue explicitly stipulate that “ordinary testing or inspection of materials or products for quality control” does not qualify for the R&D tax credit. Consequently, if Cargill performs routine batch testing on an already commercialized soy flour to ensure it meets pre-established specifications, those labor and supply expenses are strictly excluded. However, the experimental formulation of a novel macroscopic structure, physically developed and tested within the Plymouth innovation center, securely qualifies for both the federal and Minnesota R&D credits.

Case Study: Precision Engineering and CNC Micromachining

The extraordinary concentration of medical device original equipment manufacturers (OEMs) and aerospace companies in the Minneapolis-St. Paul region necessitates a highly advanced, localized supply chain capable of producing hyper-precise components. Companies such as Graham Research and Trelleborg Medical Solutions have established advanced manufacturing centers in Plymouth to provide sophisticated contract engineering and Computer Numerical Control (CNC) micromachining services. These firms operate under the most stringent regulatory environments, adhering to International Traffic in Arms Regulations (ITAR) for defense and ISO 13485 standards for medical components.

When a Plymouth-based precision machine shop is contracted to manufacture a novel titanium structural bracket for a defense aerospace client, requiring tolerances down to +0.0001 inches, the activity constitutes qualified research. The work relies on mechanical engineering and metallurgy. The objective is to develop a unique manufacturing process, custom tooling, and specific CNC programming capable of producing the complex geometry repeatedly and at volume. The facility faces uncertainty regarding how the specific titanium alloy will react to standard cutting speeds, presenting a high risk of thermal warping or tool fracture. The engineers design custom holding fixtures, program alternative toolpaths using Computer-Aided Manufacturing (CAM) software, and conduct test runs, continuously adjusting feed rates and coolant applications based on microscopic metrology data until the required tolerance is stabilized.

However, contract manufacturers in Plymouth face a unique statutory hurdle known as the “funded research exclusion.” As established in the precedent of Meyer, Borgman & Johnson, Inc. v. Commissioner, a taxpayer cannot claim the R&D credit if the research is funded by a client. Research is considered funded if the payment is not contingent on the success of the research, or if the taxpayer does not retain substantial rights to the research results. Therefore, the precision manufacturer in Plymouth can only claim the R&D credit for this project if their contract with the aerospace client is fixed-price, meaning the Plymouth firm bears the economic risk if the machining process fails, and if the Plymouth firm retains the intellectual property rights to the manufacturing processes and CNC codes developed during the engagement. If the manufacturer is compensated purely on a time-and-materials basis regardless of the outcome, the aerospace client, not the Plymouth manufacturer, possesses the right to claim the credit.

Case Study: Health-Tech Software and IoT Infrastructure

The convergence of Minnesota’s legacy in supercomputing, initiated by firms like Control Data Corporation and IBM in the mid-20th century, with its dominance in medical technology has given rise to a vibrant digital health and software sector. Plymouth hosts numerous firms developing the Internet of Medical Things (IoMT) infrastructure, advanced data analytics, and complex therapeutic software. For instance, HistoSonics, utilizing a hybrid operational presence in Plymouth, develops sophisticated software platforms that control non-invasive sonic beam therapies (histotripsy).

Developing the software interface, cloud integration, and control algorithms for a medical device involves intense, credit-eligible R&D. The technological nature of the work relies on computer science, software architecture, and network engineering. The permitted purpose is to improve the device’s functional algorithms, enabling real-time ultrasound image compression and secure cloud connectivity for remote patient monitoring. Software architects face severe technical uncertainty regarding how to securely transmit high-fidelity imaging data to cloud environments with zero latency while strictly maintaining compliance with Health Insurance Portability and Accountability Act (HIPAA) and IEC 62304 regulations. The process of experimentation involves Agile development methodologies, writing source code, conducting exhaustive unit and integration testing, refactoring code to optimize central processing unit (CPU) load, and performing simulated cybersecurity stress tests.

Federal Treasury Regulations distinguish heavily between software developed for commercial sale or license and “Internal Use Software” (IUS). Software developed primarily for a company’s internal administrative or management functions faces a substantially higher statutory hurdle to qualify for R&D credits, known as the High Threshold of Innovation test. However, because the software developed by health-tech firms in Plymouth is either embedded directly into a medical device sold to hospitals or is specifically designed to interact with third parties such as physicians and patients, it effectively escapes the restrictive IUS classification. Consequently, the W-2 wages of the local software developers and engineers represent highly lucrative qualified expenditures for both the federal and state tax credits.

Detailed Analysis of United States Federal R&D Tax Credit Requirements

The federal R&D tax credit, formally titled the Credit for Increasing Research Activities, is codified under Section 41 of the Internal Revenue Code. Enacted in 1981 to prevent the offshoring of American innovation, the credit represents a cornerstone of United States industrial policy, offering a dollar-for-dollar reduction against federal income tax liabilities. While the credit is highly valuable, the regulatory environment governing its application is incredibly complex, requiring rigorous contemporaneous documentation and precise accounting methodologies.

The Statutory Framework: The Four-Part Test

To qualify for the federal credit, a business must demonstrate that its activities meet the statutory definition of “qualified research.” This definition is strictly governed by a four-part test, and failure to satisfy any single element results in the disqualification of the associated expenditures.

The first prong is the Discovering Technological Information Test, which mandates that the research must fundamentally rely on the principles of the hard sciences, specifically engineering, computer science, biological sciences, or physical sciences. The IRS explicitly excludes activities that rely on the social sciences, arts, or humanities. The second prong, the Business Component Test, requires that the objective of the research must be to create a new or improved product, process, computer software, technique, formula, or invention to be held for sale, lease, or license, or used by the taxpayer in a trade or business. The improvement must specifically relate to the component’s performance, functionality, quality, or reliability. Aesthetic or cosmetic improvements do not qualify.

The third prong is the Elimination of Uncertainty Test. At the onset of the project, the taxpayer must encounter technological uncertainty regarding the capability of developing the business component, the method of developing it, or the appropriate design of the component. The taxpayer is not required to be attempting a scientific breakthrough; uncertainty exists if the information available to the taxpayer does not establish the exact method or design required to achieve the desired specification. The fourth and most heavily scrutinized prong is the Process of Experimentation Test. The taxpayer must engage in a systematic process designed to evaluate one or more alternatives to achieve the intended result and eliminate the identified uncertainty. This process involves modeling, simulation, systematic trial and error, or other rigorous methods of hypothesis testing.

Qualified Research Expenses (QREs)

Upon satisfying the four-part test, specific financial expenditures tied to the qualified activity can be captured as Qualified Research Expenses (QREs) under Section 41(b)(1). The federal code recognizes four primary categories of QREs:

• Wages: The most significant driver of the credit, this includes the W-2 taxable wages paid to employees for the time they spend directly performing, directly supervising, or directly supporting the qualified research.
• Supplies: This covers the cost of tangible property that is used and consumed during the research and development process, such as prototype materials, testing chemicals, or engineering resins. The code strictly excludes land, capital equipment subject to depreciation, and general administrative supplies.
• Contract Research: Payments made to third-party contractors, engineering firms, or testing laboratories performing qualified research on behalf of the taxpayer. By statute, these expenses are typically limited to 65 percent of the invoiced amount, acknowledging that the contractor’s invoice includes an embedded profit margin.
• Computer Rental and Cloud Hosting: Costs associated with renting computers or utilizing cloud hosting environments (such as AWS or Microsoft Azure) specifically to conduct research and development, compile code, or run complex simulations.

The Evolution of IRC Section 174 and Section 174A

The definition and utilization of QREs under Section 41 are fundamentally tied to IRC Section 174, which dictates the broader accounting treatment of research and experimental (R&E) expenditures. For decades, taxpayers enjoyed the ability to immediately deduct all R&E expenditures in the tax year they were incurred. However, the Tax Cuts and Jobs Act (TCJA) of 2017 introduced a massive paradigm shift. Effective for tax years beginning after December 31, 2021, the TCJA mandated that all taxpayers must capitalize their R&E expenditures and amortize them over a five-year period for domestic research, and a fifteen-year period for foreign research. This capitalization requirement severely restricted corporate cash flow, artificially inflated taxable income in the short term, and created a significant disincentive for domestic innovation.

Recognizing the detrimental macroeconomic impact, the federal government reversed course with the enactment of the “One Big Beautiful Bill Act” (OBBBA), signed into law on July 4, 2025. The OBBBA introduced the new IRC Section 174A, which permanently restored the ability of taxpayers to fully and immediately deduct domestic R&E expenditures in the year they are paid or incurred, effective for tax years beginning after December 31, 2024. Crucially, while domestic expenses can now be expensed, foreign R&E expenditures must continue to be capitalized and amortized over 15 years, creating a powerful tax strategy incentive to onshore research operations to domestic hubs like Plymouth, Minnesota. The legislation also included transition rules allowing qualified small businesses to retroactively deduct unamortized R&E from the 2022 through 2024 tax years via amended returns.

Form 6765 Administrative Updates for 2024 and 2025

The restoration of favorable expensing rules under Section 174A has been accompanied by a significant increase in administrative scrutiny from the IRS regarding Section 41 credit claims. Following a directive issued in late 2021 demanding greater specificity in refund claims, the IRS finalized sweeping changes to Form 6765 (Credit for Increasing Research Activities) in December 2024.

The most consequential addition is Section G, titled “Business Component Information.” Historically, taxpayers aggregated their total QREs across the entire company to calculate the credit. Section G now requires taxpayers to disaggregate and report their data at the individual project or business component level. For every distinct business component claimed, the taxpayer must provide the name and type of the component, detail the specific scientific uncertainties and the alternatives evaluated, and report the precise allocation of qualified wages, supplies, and contract research expenses. To facilitate the transition, the IRS made Section G optional for the 2024 tax year, but it becomes strictly mandatory for tax years beginning after December 31, 2024. The only exemptions to the Section G requirement are for Qualified Small Businesses (QSBs) electing the payroll tax credit, and taxpayers with $50 million or less in gross receipts who are claiming $1.5 million or less in QREs on an originally filed return.

Precedential Federal Case Law

The necessity of the expanded reporting requirements under Form 6765 Section G is underscored by recent United States Tax Court decisions, which have consistently ruled against taxpayers lacking granular, contemporaneous documentation.

In the 2024 case Phoenix Design Group, Inc. v. Commissioner, the Tax Court completely disallowed the R&D credits claimed by an engineering firm and imposed a 20 percent accuracy-related penalty. The court ruled that the taxpayer failed to identify specific technological uncertainties before commencing their research activities. The ruling established that generalized claims of uncertainty regarding design challenges are insufficient; the IRS expects clear documentation defining the exact scientific parameters the research seeks to resolve, mapped directly to a demonstrable process of experimentation.

Furthermore, the complexities of contract manufacturing and engineering, prevalent in Plymouth’s industrial parks, were highlighted in Meyer, Borgman & Johnson, Inc. v. Commissioner. This case centered on the “funded research” exclusion under IRC Section 41, which denies the credit if the research is funded by a third party. The court meticulously analyzed the structural engineering firm’s client contracts, determining that because the firm was paid regardless of the ultimate success of the design, the research was funded, and the credit was disallowed. This ruling mandates that service providers must bear the economic risk of development failure to validly claim the federal credit.

Detailed Analysis of Minnesota State R&D Tax Credit Laws

Minnesota’s legislative approach to the R&D tax credit demonstrates a sustained, strategic effort to anchor technological development within its borders. Enacted by the Minnesota Legislature in 1981, the state became the first in the nation to establish a localized version of the federal credit. Formally known as the Credit for Increasing Research Activities, codified under Minnesota Statutes Section 290.068, the incentive is structurally patterned after IRC Section 41 but contains several pivotal geographic, mathematical, and administrative distinctions.

Core Distinctions from Federal Law

The most defining characteristic of the Minnesota R&D tax credit is its strict geographic limitation. While the federal credit applies to any research conducted within the United States, Minnesota law dictates that all QREs claimed for the state credit must be generated by research physically conducted within the borders of Minnesota. If a company headquartered in Plymouth directs research that is ultimately executed in a laboratory in Wisconsin, those expenditures are entirely excluded from the Minnesota calculation.

Furthermore, Minnesota deviates from the federal government regarding calculation methodologies. The federal code allows taxpayers to choose between the Regular Incremental method and the Alternative Simplified Credit (ASC) method, the latter of which relies on a moving average of recent QREs. Minnesota law explicitly prohibits the use of the federal ASC method. All taxpayers in Minnesota must calculate their credit using the traditional incremental method, which compares current-year QREs against a historically derived “base amount” to ensure the credit only rewards a genuine increase in research intensity.

Additionally, the state enforces specific exclusions beyond the federal parameters. Most notably, any R&D expenditures that are funded by an Innovation Grant provided by the Minnesota Department of Employment and Economic Development (DEED) are automatically disqualified from being claimed as QREs for the state credit, preventing the double-dipping of state subsidies.

Credit Calculation and 2025 Refundability Rules (H.F. 9)

The Minnesota Credit for Increasing Research Activities applies a tiered rate structure to the pool of qualified Minnesota expenses that exceed the computed base amount. The statutory rates are:

• 10 Percent: Applied to the first $2,000,000 of qualifying Minnesota expenses over the base amount.
• 4 Percent: Applied to all qualifying Minnesota expenses that exceed the initial $2,000,000 threshold.

Historically, the Minnesota R&D credit was strictly nonrefundable. If the generated credit exceeded a corporation’s current Minnesota franchise or income tax liability, the excess could not be converted to cash; it could only be carried forward to offset future tax liabilities for a maximum of 15 years.

This dynamic was fundamentally altered with the enactment of omnibus tax legislation, House File 9 (H.F. 9), signed by Governor Tim Walz on June 14, 2025. The legislation recognized that strictly nonrefundable credits offered little immediate utility to highly innovative, pre-revenue biotech startups or manufacturing firms operating in net operating loss (NOL) positions. To resolve this, H.F. 9 introduced partial refundability for the Minnesota R&D credit for the first time.

For tax years beginning after December 31, 2024, taxpayers can make an irrevocable election on their timely filed original return (including extensions) to receive a cash refund for a portion of their unused credits. The legislation establishes a staggered progression of refundability rates to manage the fiscal impact on the state’s general fund:

• Tax Year 2025: 19.2% of the excess credit remaining after reducing tax liability to zero is refundable.
• Tax Years 2026 and 2027: The refundability rate increases to 25% of the excess credit.
• Tax Year 2028 and Beyond: The credit remains refundable, but it is capped at the lesser of 25% or a dynamic rate determined annually by the Department of Revenue, designed to ensure that the cumulative total of R&D refunds issued statewide does not exceed approximately $25 million per year.

Any remaining portion of the generated credit that is not refunded under these calculations is preserved and carried forward under the standard 15-year rule.

Minnesota Department of Revenue Guidance and Judicial Precedent

The application of Minnesota Statute Section 290.068 is heavily dictated by judicial precedent established by the Minnesota Tax Court and the Minnesota Supreme Court. These courts are frequently tasked with resolving the complex mathematical interplay between state statutes and the incorporated federal definitions from IRC Section 41.

The most consequential ruling in recent jurisprudence is General Mills, Inc. v. Commissioner of Revenue (931 N.W.2d 791, Minn. 2019). The litigation centered on the precise calculation of the “base amount.” The base amount is derived by multiplying a taxpayer’s historical “fixed-base percentage” (the ratio of historical QREs to historical gross receipts) by their average annual gross receipts for the prior four years.

In General Mills, the Minnesota Supreme Court affirmed two critical points regarding the mechanics of the state credit:

1. The Minimum Base Amount Limitation: The Court ruled that by incorporating the federal definition of “base amount” into state law, the Minnesota legislature implicitly adopted the federal “minimum base amount” limitation found in IRC Section 41(c)(2). Consequently, for the purposes of the Minnesota calculation, a taxpayer’s base amount can never be less than 50 percent of their current-year QREs. This mathematically limits the maximum potential credit for highly research-intensive companies, ensuring that at least half of current spending is viewed as baseline activity rather than incremental growth.
2. The Definition of Gross Receipts: The Court ruled that for the 2011 tax year in question, the term “aggregate gross receipts” used to calculate the fixed-base percentage referred to the company’s total federal global gross receipts, rather than just its Minnesota-apportioned receipts, even though the QREs were strictly limited to Minnesota. While this ruling established a precedent that state courts will strictly enforce federal definitions unless explicitly overridden by state statute, the Minnesota legislature subsequently amended the law. For tax years after May 30, 2017, the statute explicitly mandates that Minnesota-apportioned sales or gross receipts must be used to calculate the base amount.

State courts also rigorously defend the boundaries of the four-part test. In the 2024 case Uline, Inc. v. Commissioner of Revenue, the Minnesota Supreme Court affirmed that routine marketing research performed by sales representatives is not protected from state income taxation and does not qualify as R&D. This ruling reinforced the strict enforcement of the federal exclusion of market and consumer research from QRE eligibility within the state.

Financial Impact Simulation for a Plymouth Enterprise

To demonstrate the tangible financial impact of the intersecting federal and state statutes, consider a hypothetical mid-sized health-tech software developer headquartered in Plymouth, Minnesota. The firm is currently in a pre-revenue, loss-generating position, heavily investing in the development of a cloud-based predictive analytics platform for cardiovascular diagnostics.

During the 2025 tax year, the firm incurs $1,045,800 in eligible Minnesota QREs, consisting entirely of W-2 wages for software engineers operating out of their Plymouth facility and the associated cloud hosting fees required for development. Based on their historical spending patterns and Minnesota-apportioned gross receipts, their calculated base amount is determined to be $522,900.

Because the firm operates in a net operating loss position, it has $0 in current Minnesota state income tax liability. Historically, the $52,290 state credit would simply carry forward, providing no immediate liquidity. However, under the 2025 H.F. 9 refundability provisions, the firm can make an irrevocable election on its Schedule RD to receive a cash refund. For tax year 2025, the refundability rate is 19.2%.

The firm receives an immediate, non-dilutive capital injection of $10,039.68 from the Minnesota Department of Revenue ($52,290 x 19.2%). The remaining balance of $42,250.32 is preserved and carried forward to offset state tax liabilities for up to 15 years. Concurrently, under the federal OBBBA legislation, the firm can immediately deduct the entirety of the $1,045,800 in domestic R&E expenditures under IRC Section 174A, bypassing the restrictive five-year capitalization rules of the TCJA era.

Final Thoughts

The industrial evolution of Plymouth, Minnesota, from a rural milling community to a sophisticated node within the Medical Alley network is a testament to the compounding effects of strategic infrastructure investment and targeted tax policy. The city’s concentration of medical device manufacturers, HVAC engineering firms, food science laboratories, precision machinists, and health-tech software developers represents the exact type of high-value economic activity that R&D tax credits are designed to cultivate.

The United States federal R&D tax credit, significantly bolstered by the OBBBA’s restoration of immediate domestic R&E expensing under Section 174A, provides a massive incentive to localize research operations. Parallel to this, Minnesota’s statutory framework under Section 290.068, enhanced by the 2025 H.F. 9 partial refundability provisions, ensures that both established Fortune 500 corporations and pre-revenue startups in Plymouth can monetize their innovation investments.

However, the regulatory environment is increasingly unforgiving. As evidenced by the IRS’s implementation of Form 6765 Section G, which mandates granular business component-level reporting, and strict judicial interpretations in cases such as General Mills, Inc. v. Commissioner and Phoenix Design Group, Inc. v. Commissioner, tax authorities demand unprecedented precision in documentation. To successfully secure these credits, enterprises in Plymouth must adopt proactive, highly structured methodologies that clearly identify technical uncertainties at the inception of a project and rigorously document the subsequent process of experimentation. By aligning their localized engineering and development activities with the strict parameters of state and federal tax law, Plymouth’s industries can substantially reduce their tax liabilities, reinvest in their specialized workforce, and maintain a decisive competitive advantage in the global market.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.